Dipeptidyl peptidase-4 inhibitors and fracture risk: an updated meta-analysis of randomized clinical trials

Data on the effects of dipeptidyl peptidase-4 (DPP-4) inhibitors on fracture risk are conflicting. Here, we performed a systematic review and meta-analysis of randomized controlled trials (RCTs) assessing the effects of DPP-4 inhibitors. Electronic databases were searched for relevant published arti...

Descripción completa

Detalles Bibliográficos
Autores principales: Fu, Jianying, Zhu, Jianhong, Hao, Yehua, Guo, Chongchong, Zhou, Zhikun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935882/
https://www.ncbi.nlm.nih.gov/pubmed/27384445
http://dx.doi.org/10.1038/srep29104

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4935882/
https://www.ncbi.nlm.nih.gov/pubmed/27384445
http://dx.doi.org/10.1038/srep29104

Ejemplares similares